---
document_datetime: 2023-09-21 19:14:43
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/evoltra-epar-all-authorised-presentations_en.pdf
document_name: evoltra-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.990598
conversion_datetime: 2025-12-25 07:40:15.205585
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical Form                   | Route of Administration   | Packaging    | Content   | Package size   |
|-----------------|-----------------|------------|---------------------------------------|---------------------------|--------------|-----------|----------------|
| EU/1/06/334/001 | Evoltra         | 1 mg/ml    | Concentrate for solution for infusion | Intravenous use           | vial (glass) | 20 ml     | 3 vials        |
| EU/1/06/334/002 | Evoltra         | 1 mg/ml    | Concentrate for solution for infusion | Intravenous use           | vial (glass) | 20 ml     | 4 vials        |
| EU/1/06/334/003 | Evoltra         | 1 mg/ml    | Concentrate for solution for infusion | Intravenous use           | vial (glass) | 20 ml     | 10 vials       |
| EU/1/06/334/004 | Evoltra         | 1 mg/ml    | Concentrate for solution for infusion | Intravenous use           | vial (glass) | 20 ml     | 20 vials       |
| EU/1/06/334/005 | Evoltra         | 1 mg/ml    | Concentrate for solution for infusion | Intravenous use           | vial (glass) | 20 ml     | 1 vial         |